Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 457 clinical trials
Ivermectin and Doxycycine in COVID-19 Treatment

Efficacy of Ivermectin and Doxycycline in COVID-19 treatment

chloroquine
covid-19
doxycycline
ivermectin
  • 0 views
  • 19 Feb, 2024
  • 1 location
Hemostasis in COVID-19: an Adaptive Clinical Trial

Hypercoagulability has been demonstrated in COVID-19, leading to respiratory distress and increased mortality. This is adaptive clinical trial to compare effectiveness and safety of four therapeutic strategies in hospital mortality in patients with COVID-19: standard prophylaxis, therapeutic dose anticoagulation, inhaled UFH associated with standard prophylaxis and ASA associated with standard …

thrombophilia
aspirin
respiratory distress
covid-19
hemostasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid-19) broke out in Wuhan, China. Some patients rapidly progressed and suffered severe acute respiratory failure and died, making it imperative to develop a safe and effective vaccine to treat and prevent severe Covid-19 pneumonia.

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)

The study will evaluate the efficacy and safety of aprepitant injectable emulsion added to standard of care for hospitalized patients with COVID-19.

acute respiratory syndrome (sars)
mechanical ventilation
PCR test
covid-19
SARS
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Safety and Efficacy of C21 in Subjects With COVID-19

This is a randomised, double-blind, placebo-controlled phase 2 trial investigating the safety and efficacy of C21 in subjects who are hospitalised with COVID-19 infection, but not in need of mechanical invasive or non-invasive ventilation. In total, approximately 100 subjects will be enrolled and randomised to receive twice daily oral administration …

acute respiratory syndrome (sars)
PCR test
SARS
respiratory tract infection
acute respiratory infections
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Preliminary reports have been received from several sources that the periodic inhaling of water with a heightened level of kinetic activity has lessened the severity of symptoms in Covid-19 infected patients. On at least several occasions, a repeat PCR test performed two days after inhaling a particular water-based product was …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Effect of Quercetin on Prophylaxis and Treatment of COVID-19

Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19 goes with excessive immune reaction of human body in severe cases. The investigators hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be effective on both prophylaxis and treatment of COVID-19 cases.

coronavirus infection
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

This is a randomized, double-blind, placebo-controlled, multicenter, Phase 3 study to evaluate if high-dose Octagam 10% therapy can stabilize or improve clinical status in patients with severe Coronavirus disease

pao2
fraction of inspired oxygen (fio2)
FIO2
pao2/fio2 ratio
coronavirus infection
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients

The study is devoted to the comparative analysis of the data received in patients with COVID-19 lung pathology using the method of probe-based confocal laser endomicroscopy of distal airways and two reference methods: high resolution computed tomography and morphology (in some patients).

pneumonia
critical illness
chronic obstructive pulmonary disease
ct scan
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID 19)

This is a prospective, phase 2, multicenter, randomized, double blind, placebo controlled, parallel group study to assess the safety and efficacy of CSL312 administered intravenously, in combination with standard of care (SOC) treatment, in patients with Coronavirus disease 2019 (COVID 19)

pao2
PCR test
pneumonia
molecular diagnostic
FIO2
  • 0 views
  • 19 Feb, 2024
  • 1 location